Anne Durandy

Dr. Anne Durandy

orcid

Research Focus & Metrics

Academic Career Length

52Years (1975-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2000 in Cell
Verified
Journal Article
Closed access
PRPatrick Revy
Patrick Revy
TMTaro Muto
Taro Muto
YLYves Levy
Yves Levy
FGFrédéric Geissmann
Frédéric Geissmann
APAlessandro Plebani
Alessandro Plebani
ADAnne Durandy
Anne Durandy

1 March 2001 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
RDRainer Döffinger
Rainer Döffinger
ASAsma Smahi
Asma Smahi
CBChristine Bessia
Christine Bessia
FGFrédéric Geissmann
Frédéric Geissmann
JFJacqueline Feinberg
Jacqueline Feinberg
JCJean-Laurent Casanova
Jean-Laurent Casanova

1 February 2009 in Cell
Verified
Journal Article
Closed access
GSGrant S. Stewart
Grant S. Stewart
SPStephanie Panier
Stephanie Panier
KTKelly Townsend
Kelly Townsend
AAAbdallah K. Al-Hakim
Abdallah K. Al-Hakim
NKNadine K. Kolas
Nadine K. Kolas
DDDaniel Durocher
Daniel Durocher

29 May 1998 in Science
Verified
Journal Article
Closed access
PDF file
FAFrédéric Altare
Frédéric Altare
ADAnne Durandy
Anne Durandy
DLDavid Lammas
David Lammas
JEJean-François Emile
Jean-François Emile
SLSalma Lamhamedi
Salma Lamhamedi
JCJean-Laurent Casanova
Jean-Laurent Casanova
In humans, interferon γ (IFN-γ) receptor deficiency leads to a predisposition to mycobacterial infections and impairs the formation of mature granulomas. Interleukin-12 (IL-12) receptor deficiency was found in otherwise healthy individuals with mycobacterial infections. Mature granulomas were seen, surrounded by T cells and centered with epithelioid and multinucleated giant cells, yet reduced IFN-γ concentrations were found to be secreted by activated natural killer and T cells. Thus, IL-12–dependent IFN-γ secretion in humans seems essential in the control of mycobacterial infections, despite the formation of mature granulomas due to IL-12–independent IFN-γ secretion.

1 January 2006 in Cell
Verified
Journal Article
Closed access
DBDietke Buck
Dietke Buck
LMLaurent Malivert
Laurent Malivert
RCRégina de Chasseval
Régina de Chasseval
ABAnne Barraud
Anne Barraud
MFMarie-Claude Fondanèche
Marie-Claude Fondanèche
PRPatrick Revy
Patrick Revy

15 November 2013 in Science
Verified
Journal Article
Closed access
PDF file
IAIvan Angulo
Ivan Angulo
OVOscar Vadas
Oscar Vadas
FGFabien Garçon
Fabien Garçon
EBEdward Banham-Hall
Edward Banham-Hall
VPVincent Plagnol
Vincent Plagnol
SNSergey Nejentsev
Sergey Nejentsev
Answers from Exomes: Exome sequencing, which targets only the protein-coding regions of the genome, has the potential to identify the underlying genetic causes of rare inherited diseases. Angulo et al. (p. 866 , published online 17 October; see Perspective by Conley and Fruman ) performed exome sequencing of individuals from seven unrelated families with severe, recurrent respiratory infections. The patients carried the same mutation in the gene coding for the catalytic subunit of phosphoinositide 3-kinase δ (PI3Kδ). The mutation caused aberrant activation of this kinase, which plays a key role in immune cell signaling. Drugs inhibiting PI3Kδ are already in clinical trials for other disorders.